Prophylactic medication for the prevention of endoscopic recurrence in Crohn’s disease: a prospective study based on clinical risk stratification

Jeanine H C Arkenbosch, Evelien M J Beelen, Gerard Dijkstra, Mariëlle Romberg-Camps, Marjolijn Duijvestein, Frank Hoentjen, Sander van der Marel, P W Jeroen Maljaars, Sita Jansen, Nanne K H de Boer, Rachel L West, Carmen S Horjus, Laurents P S Stassen, Fiona D M van...

Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study

M M van de Meeberg, M L Seinen, H H Fidder, M Lin, B Oldenburg, N K de Boer, G Bouma, R de Jonge, M Bulatović Ćalasan, Dutch Initiative on Crohn and Colitis (ICC) BMC Gastroenterol. 2022 Jul 30;22(1):365. doi: 10.1186/s12876-022-02439-y.

Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases

Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein, Amber Sales, Amit Levran, Fiona van Schaik, Jeroen Maljaars, Krisztina Gecse, Cyriel Ponsioen, Joep Grootjans, Jurij Hanzel, Greetje Tack, Jeroen Jansen, Frank Hoentjen, Nanne de Boer, Sander van der...

Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study

Tessa Straatmijer, Vince BC Biemans, Marijn Visschedijk, Frank Hoentjen, Annemarie de Vries, Adriaan A van Bodegraven, Alexander Bodelier, Nanne KH de Boer, Gerard Dijkstra, Noortje Festen, Carmen Horjus, Jeroen M Jansen, Bindia Jharap, Wout Mares, Fiona DM van...

The launch of an online national multidisciplinary expert panel for inflammatory bowel disease

Nanne K de Boer, Florine L van Lookeren, Greetje J Tack, Dutch Initiative on Crohn and Colitis (ICC) J Crohns Colitis. 2022 Jan 6;jjac002. doi: 10.1093/ecco-jcc/jjac002. Online ahead of print